Research, Development and Production of novel therapeutics for infectious diseases as well as environmentally caused chronic illnesses. Our company developed a unique formulation (FSMP certified), that successfully, completed Human Clinical Trials on Covid19 patients, showing significant improvements as add on therapy to the already successful Indian Standard Treatment Protocol. Accelerated Viral clearance, significant improvements in Lung damages, Myocardial markers and increase in antibody levels were documented. We were the first company to include Long/Post Covid monitoring into a Clinical Trial setting and showing efficacy for prevention & improvement on this new condition that seems difficult to treat. In addition, the animal trials on Myocardial Infarction showed significant protection of heart muscle tissues. The feedback on this project is very reassuring and we are one of the few companies to successfully develop a novel product for Covid19/Long Covid treatment so to speak “from scratch”. Our challenge as a new company, being formed for this single purpose, is to make these outstanding results known to a wider circle of experts and patients and help to make a difference in these challenging times. We trust in the quality of our product, as quality, paired with good intentions. will always prevail!